PE anti-human CD158b (KIR2DL2/KIR2DL3) Antibody, CD158b, S22037G,BioLegend,317509

Clone S22037G can block the binding of clone DX27 on target cells.Based on in-house testing on different KIR-expressing transfectants, clone S22037G does not interact with other KIR protein family members.

Host

Mouse

Reactivity

Human

Application

FC - Quality tested

Platform ID

BAB574780968

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePE anti-human CD158b (KIR2DL2/KIR2DL3) Antibody, CD158b, S22037G
Cat. No.317509
HostMouse
RRIDAB_3720519 (BioLegend Cat. No. 317510)
IsotypeMouse IgG2a, κ
ReactivityHuman
ApplicationFC - Quality tested
ClonalityMonoclonal
Clone NumberS22037G
ConcentrationLot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysisonline tool).
TargetCD158b
ImmunogenHuman KIR2DL2 transfected cells
PurityThe antibody was purified by affinity chromatography and conjugated with PE under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
StorageThe antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

CD158 molecules, also known as KIRs (killer cell immunoglobulin-like receptors), are a family of transmembrane proteins with either two (KIR2D) or three (KIR3D) Ig-like extracellular domains. Some KIRs with long cytoplasmic domains contain ITIMs and possess inhibitory functions and others with short cytoplasmic region lack ITIM and have activation functions. Fifteen polymorphic KIR genes have been reported in humans.CD158b1 and CD158b2 are 38 kD two extracellular Ig domain glycoprotein that displays a long cytoplasmic tail with ITIM motifs. It is expressed primarily on a subset of NK cells and a subset of T cells. KIR2DL2 and KIR2DL3 have been reported to bind to certain HLA-C antigens on a target cell (HLA-C*01, HLA-C*03, HLA-C*07, for example).

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.